Production technology of royal jelly and bee venom
10.3390/molecules29215138 182
Potential Benefits Soft-tissue repair (preclinical): Animal studies report faster wound healing via TB-500-driven angiogenesis and cell migration, plus BPC-157-associated tendon, ligament and gut healing [5] [6]
On October 22, 2024, Novo Nordisk submitted a nomination to the FDA, arguing that semaglutide products belong on the Demonstrable Difficulties for Compounding (DDC) list due to the complexities associated with their formulations, delivery mechanisms, dosage forms, achievement of bioavailability, compounding processes, and physicochemical and analytical testing. The FDA has yet to make a final decision on whether to ban compounded versions of semaglutide
A study that looked at 0.5-1mg/kg/day leucovorin in patients with cerebral folate deficiency (and related neurological symptoms) found that 90% of those supplemented achieved normal 5-methyltetrahydrofolate cerebral spinal fluid concentrations